4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-041953
Chief Scientific Officer acquired 3,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Biller Scott · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-06-23 | Exercise or conversion : show line 1 in the form | +3,000 | $0.47 | $1,403 | 6,264 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-06-23 | Exercise or conversion : show line 2 in the form Stock option (right to buy) | −3,000 | 14,875 | D |
Loading xslF345X03/doc4.xml…